Advanced Parenteral Drug Delivery Market Report

Advanced Parenteral Drug Delivery Market - Global Professional Analysis and Forecast to 2026

  • POSTDATE：Oct 23, 2019
  • PAGES：180
  • REPORT CODE：GMM343474
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The worldwide Advanced Parenteral Drug Delivery market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 8.9% during the forecast period.

    This report presents the market size and development trends by detailing the Advanced Parenteral Drug Delivery market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Advanced Parenteral Drug Delivery market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Advanced Parenteral Drug Delivery industry and will help you to build a panoramic view of the industrial development.

    Advanced Parenteral Drug Delivery Market, By Type:

    • Prefillable Syringes

    • Injectors Cartridges

    • Hypodermic Syringes

    • IV Catheters

    • Other Parenteral Delivery Devices

    Advanced Parenteral Drug Delivery Market, By Application:

    • Central Nervous System Agents

    • Respiratory Agents

    • Hormones & Related Agents

    • Gastrointestinal Agents

    • Cardiovascular Agents

    • Anti-Infective Agents

    • Nutritional Agents

    • Genito-Urinary Agents

    Some of the leading players are as follows:

    • Dickinson

    • Amgen

    • GlaxoSmithKline

    • Hoffmann-La Roche

    • AstraZeneca

    • Bristol-Myers Squibb

    • Novartis

    • Abbott Laboratories

    • Boston Scientific

    • Baxter

    • Becton

    • AptarGroup

    • Pfizer

    Geographically, Major regions are analyzed in details are as follows:

    • North America

    • Europe

    • Asia Pacific

    • Latin America

    • Middle East & Africa

  • Table of Contents

    1 Methodology and Scope

    • 1.1 Market Segmentation & Scope

      • 1.1.1 Technology Type

      • 1.1.2 Product

      • 1.1.3 Application

      • 1.1.4 Regional scope

      • 1.1.5 Estimates and forecast timeline

    • 1.2 Research Methodology

    • 1.3 Information Procurement

      • 1.3.1 Purchased database

      • 1.3.2 Internal database

      • 1.3.3 Secondary sources

      • 1.3.4 Primary research

      • 1.3.5 Details of primary research

    • 1.4 Information or Data Analysis

      • 1.4.1 Data analysis models

    • 1.5 Market Formulation & Validation

    • 1.6 Model Details

      • 1.6.1 Commodity flow analysis

      • 1.6.2 Volume price analysis

    • 1.7 List of Secondary Sources

    • 1.8 List of Abbreviations

    2 Executive Summary

    • 2.1 Market Outlook

    • 2.2 Segment Outlook

    3 Market Variables, Trends, & Scope

    • 3.1 Market Lineage Outlook

    • 3.1.1 Parent market outlook

      • 3.1.2 Ancillary market outlook

    • 3.2 Market Segmentation

      • 3.2.1 Analysis

    • 3.3 Market Dynamics

      • 3.3.1 Market driver analysis

      • 3.3.2 Market restraint analysis

      • 3.3.3 Industry opportunities

    • 3.4 Penetration & Growth Prospect Mapping

      • 3.4.1 Penetration & growth prospect mapping analysis

    • 3.5 Business Environment Analysis Tools

      • 3.5.1 Porter's five forces analysis

      • 3.5.2 PESTLE analysis

      • 3.5.3 Major deals & strategic alliances analysis

    4 Advanced Parenteral Drug Delivery Market: Technology Type Analysis

    • 4.1 Advanced Parenteral Drug Delivery Technology Type Market Share Analysis, 2018 & 2026

    • 4.2 Advanced Parenteral Drug Delivery Technology Type Market: Segment Dashboard

    • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

      • 4.3.1 Prefillable Syringes

      • 4.3.2 Injectors Cartridges

      • 4.3.3 Hypodermic Syringes

      • 4.3.4 IV Catheters

      • 4.3.5 Other Parenteral Delivery Devices

    5 Advanced Parenteral Drug Delivery Market: Product Analysis

    • 5.1 Advanced Parenteral Drug Delivery Product Market Share Analysis, 2018 & 2026

    • 5.2 Advanced Parenteral Drug Delivery Product Market: Segment Dashboard

    • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

    6 Advanced Parenteral Drug Delivery Market: Application Analysis

    • 6.1 Advanced Parenteral Drug Delivery Application Market Share Analysis, 2018 & 2026

    • 6.2 Advanced Parenteral Drug Delivery Application Market: Segment Dashboard

    • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

      • 6.3.1 Central Nervous System Agents

      • 6.3.2 Respiratory Agents

      • 6.3.3 Hormones & Related Agents

      • 6.3.4 Gastrointestinal Agents

      • 6.3.5 Cardiovascular Agents

      • 6.3.6 Anti-Infective Agents

      • 6.3.7 Nutritional Agents

      • 6.3.8 Genito-Urinary Agents

    7 Advanced Parenteral Drug Delivery Market: Regional Analysis

    • 7.1 Advanced Parenteral Drug Delivery Regional Market Share Analysis, 2018 & 2026

    • 7.2 Advanced Parenteral Drug Delivery Regional Market: Segment Dashboard

    • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

    • 7.4 List of Players at Regional Level

      • 7.4.1 North America

      • 7.4.2 Europe

      • 7.4.3 Asia Pacific

    • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

      • 7.5.1 North America

      • 7.5.2 Europe

      • 7.5.3 Asia Pacific

      • 7.5.4 Latin America

      • 7.5.5 MEA

    • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

      • 7.6.1 North America

      • 7.6.2 Europe

      • 7.6.3 Asia Pacific

      • 7.6.4 Latin America

      • 7.6.5 Middle East & Africa

    8 Competitive Analysis

    • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

    • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

    • 8.3 Vendor Landscape

      • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

    9 Company Profiles

    • 9.1 Dickinson

      • 9.1.1 Dickinson Company overview

      • 9.1.2 Financial performance

      • 9.1.3 Product benchmarking

      • 9.1.4 Strategic initiatives

      • 9.1.5 SWOT analysis

    • 9.2 Amgen

      • 9.2.1 Amgen Company overview

      • 9.2.2 Financial performance

      • 9.2.3 Product benchmarking

      • 9.2.4 Strategic initiatives

      • 9.2.5 SWOT analysis

    • 9.3 GlaxoSmithKline

      • 9.3.1 GlaxoSmithKline Company overview

      • 9.3.2 Financial performance

      • 9.3.3 Product benchmarking

      • 9.3.4 Strategic initiatives

      • 9.3.5 SWOT analysis

    • 9.4 Hoffmann-La Roche

      • 9.4.1 Hoffmann-La Roche Company overview

      • 9.4.2 Financial performance

      • 9.4.3 Product benchmarking

      • 9.4.4 Strategic initiatives

      • 9.4.5 SWOT analysis

    • 9.5 AstraZeneca

      • 9.5.1 AstraZeneca Company overview

      • 9.5.2 Financial performance

      • 9.5.3 Product benchmarking

      • 9.5.4 Strategic initiatives

      • 9.5.5 SWOT analysis

    • 9.6 Bristol-Myers Squibb

      • 9.6.1 Bristol-Myers Squibb Company overview

      • 9.6.2 Financial performance

      • 9.6.3 Product benchmarking

      • 9.6.4 Strategic initiatives

      • 9.6.5 SWOT analysis

    • 9.7 Novartis

      • 9.7.1 Novartis Company overview

      • 9.7.2 Financial performance

      • 9.7.3 Product benchmarking

      • 9.7.4 Strategic initiatives

      • 9.7.5 SWOT analysis

    • 9.8 Abbott Laboratories

      • 9.8.1 Abbott Laboratories Company overview

      • 9.8.2 Financial performance

      • 9.8.3 Product benchmarking

      • 9.8.4 Strategic initiatives

      • 9.8.5 SWOT analysis

    • 9.9 Boston Scientific

      • 9.9.1 Boston Scientific Company overview

      • 9.9.2 Financial performance

      • 9.9.3 Product benchmarking

      • 9.9.4 Strategic initiatives

      • 9.9.5 SWOT analysis

    • 9.10 Baxter

      • 9.10.1 Baxter Company overview

      • 9.10.2 Financial performance

      • 9.10.3 Product benchmarking

      • 9.10.4 Strategic initiatives

      • 9.10.5 SWOT analysis

    • 9.11 Becton

      • 9.11.1 Becton Company overview

      • 9.11.2 Financial performance

      • 9.11.3 Product benchmarking

      • 9.11.4 Strategic initiatives

      • 9.11.5 SWOT analysis

    • 9.12 AptarGroup

      • 9.12.1 AptarGroup Company overview

      • 9.12.2 Financial performance

      • 9.12.3 Product benchmarking

      • 9.12.4 Strategic initiatives

      • 9.12.5 SWOT analysis

    • 9.13 Pfizer

      • 9.13.1 Pfizer Company overview

      • 9.13.2 Financial performance

      • 9.13.3 Product benchmarking

      • 9.13.4 Strategic initiatives

      • 9.13.5 SWOT analysis

     

    The List of Tables and Figures (Totals 99 Figures and 127 Tables)

    • Figure Prefillable Syringes Advanced Parenteral Drug Delivery market, 2015 - 2026 (USD Million)

    • Figure Injectors Cartridges Advanced Parenteral Drug Delivery market, 2015 - 2026 (USD Million)

    • Figure Hypodermic Syringes Advanced Parenteral Drug Delivery market, 2015 - 2026 (USD Million)

    • Figure IV Catheters Advanced Parenteral Drug Delivery market, 2015 - 2026 (USD Million)

    • Figure Other Parenteral Delivery Devices Advanced Parenteral Drug Delivery market, 2015 - 2026 (USD Million)

    • Figure Central Nervous System Agents market, 2015 - 2026 (USD Million)

    • Figure Respiratory Agents market, 2015 - 2026 (USD Million)

    • Figure Hormones & Related Agents market, 2015 - 2026 (USD Million)

    • Figure Gastrointestinal Agents market, 2015 - 2026 (USD Million)

    • Figure Cardiovascular Agents market, 2015 - 2026 (USD Million)

    • Figure Anti-Infective Agents market, 2015 - 2026 (USD Million)

    • Figure Nutritional Agents market, 2015 - 2026 (USD Million)

    • Figure Genito-Urinary Agents market, 2015 - 2026 (USD Million)

    • Table List of players in North America

    • Table List of players in Europe

    • Table List of players in Asia Pacific

    • Table SWOT analysis

    • Table North America Advanced Parenteral Drug Delivery market, by country, 2015 - 2026 (USD Million)

    • Table North America Advanced Parenteral Drug Delivery market, by type, 2015 - 2026 (USD Million)

    • Table North America Advanced Parenteral Drug Delivery market, by product, 2015 - 2026 (USD Million)

    • Table North America Advanced Parenteral Drug Delivery market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.S. Advanced Parenteral Drug Delivery market, by type, 2015 - 2026 (USD Million)

    • Table U.S. Advanced Parenteral Drug Delivery market, by product, 2015 - 2026 (USD Million)

    • Table U.S. Advanced Parenteral Drug Delivery market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Canada Advanced Parenteral Drug Delivery market, by type, 2015 - 2026 (USD Million)

    • Table Canada Advanced Parenteral Drug Delivery market, by product, 2015 - 2026 (USD Million)

    • Table Canada Advanced Parenteral Drug Delivery market, by application, 2015 - 2026 (USD Million)

    • Table Europe Advanced Parenteral Drug Delivery market, by country, 2015 - 2026 (USD Million)

    • Table Europe Advanced Parenteral Drug Delivery market, by type, 2015 - 2026 (USD Million)

    • Table Europe Advanced Parenteral Drug Delivery market, by product, 2015 - 2026 (USD Million)

    • Table Europe Advanced Parenteral Drug Delivery market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.K. Advanced Parenteral Drug Delivery market, by type, 2015 - 2026 (USD Million)

    • Table U.K. Advanced Parenteral Drug Delivery market, by product, 2015 - 2026 (USD Million)

    • Table U.K. Advanced Parenteral Drug Delivery market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Germany Advanced Parenteral Drug Delivery market, by type, 2015 - 2026 (USD Million)

    • Table Germany Advanced Parenteral Drug Delivery market, by product, 2015 - 2026 (USD Million)

    • Table Germany Advanced Parenteral Drug Delivery market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table France Advanced Parenteral Drug Delivery market, by type, 2015 - 2026 (USD Million)

    • Table France Advanced Parenteral Drug Delivery market, by product, 2015 - 2026 (USD Million)

    • Table France Advanced Parenteral Drug Delivery market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Italy Advanced Parenteral Drug Delivery market, by type, 2015 - 2026 (USD Million)

    • Table Italy Advanced Parenteral Drug Delivery market, by product, 2015 - 2026 (USD Million)

    • Table Italy Advanced Parenteral Drug Delivery market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Spain Advanced Parenteral Drug Delivery market, by type, 2015 - 2026 (USD Million)

    • Table Spain Advanced Parenteral Drug Delivery market, by product, 2015 - 2026 (USD Million)

    • Table Spain Advanced Parenteral Drug Delivery market, by application, 2015 - 2026 (USD Million)

    • Table Asia Pacific Advanced Parenteral Drug Delivery market, by country, 2015 - 2026 (USD Million)

    • Table Asia Pacific Advanced Parenteral Drug Delivery market, by type, 2015 - 2026 (USD Million)

    • Table Asia Pacific Advanced Parenteral Drug Delivery market, by product, 2015 - 2026 (USD Million)

    • Table Asia Pacific Advanced Parenteral Drug Delivery market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table China Advanced Parenteral Drug Delivery market, by type, 2015 - 2026 (USD Million)

    • Table China Advanced Parenteral Drug Delivery market, by product, 2015 - 2026 (USD Million)

    • Table China Advanced Parenteral Drug Delivery market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Japan Advanced Parenteral Drug Delivery market, by type, 2015 - 2026 (USD Million)

    • Table Japan Advanced Parenteral Drug Delivery market, by product, 2015 - 2026 (USD Million)

    • Table Japan Advanced Parenteral Drug Delivery market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table India Advanced Parenteral Drug Delivery market, by type, 2015 - 2026 (USD Million)

    • Table India Advanced Parenteral Drug Delivery market, by product, 2015 - 2026 (USD Million)

    • Table India Advanced Parenteral Drug Delivery market, by application, 2015 - 2026 (USD Million)

    • Table Latin America Advanced Parenteral Drug Delivery market, by country, 2015 - 2026 (USD Million)

    • Table Latin America Advanced Parenteral Drug Delivery market, by type, 2015 - 2026 (USD Million)

    • Table Latin America Advanced Parenteral Drug Delivery market, by product, 2015 - 2026 (USD Million)

    • Table Latin America Advanced Parenteral Drug Delivery market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Brazil Advanced Parenteral Drug Delivery market, by type, 2015 - 2026 (USD Million)

    • Table Brazil Advanced Parenteral Drug Delivery market, by product, 2015 - 2026 (USD Million)

    • Table Brazil Advanced Parenteral Drug Delivery market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Mexico Advanced Parenteral Drug Delivery market, by type, 2015 - 2026 (USD Million)

    • Table Mexico Advanced Parenteral Drug Delivery market, by product, 2015 - 2026 (USD Million)

    • Table Mexico Advanced Parenteral Drug Delivery market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Argentina Advanced Parenteral Drug Delivery market, by type, 2015 - 2026 (USD Million)

    • Table Argentina Advanced Parenteral Drug Delivery market, by product, 2015 - 2026 (USD Million)

    • Table Argentina Advanced Parenteral Drug Delivery market, by application, 2015 - 2026 (USD Million)

    • Table MEA Advanced Parenteral Drug Delivery market, by country, 2015 - 2026 (USD Million)

    • Table MEA Advanced Parenteral Drug Delivery market, by type, 2015 - 2026 (USD Million)

    • Table MEA Advanced Parenteral Drug Delivery market, by product, 2015 - 2026 (USD Million)

    • Table MEA Advanced Parenteral Drug Delivery market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table South Africa Advanced Parenteral Drug Delivery market, by type, 2015 - 2026 (USD Million)

    • Table South Africa Advanced Parenteral Drug Delivery market, by product, 2015 - 2026 (USD Million)

    • Table South Africa Advanced Parenteral Drug Delivery market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Nigeria Advanced Parenteral Drug Delivery market, by type, 2015 - 2026 (USD Million)

    • Table Nigeria Advanced Parenteral Drug Delivery market, by product, 2015 - 2026 (USD Million)

    • Table Nigeria Advanced Parenteral Drug Delivery market, by application, 2015 - 2026 (USD Million)

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Company market position analysis

    • Table Company Profiles

    • Table Dickinson Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Amgen Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table GlaxoSmithKline Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Hoffmann-La Roche Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table AstraZeneca Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Bristol-Myers Squibb Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Novartis Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Abbott Laboratories Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Boston Scientific Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Baxter Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Becton Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table AptarGroup Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Pfizer Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US